Search research articles
Contact Us
Filters
Showing results (741-750 of 817) with videos related to
Page
of 82
Sort By:
Translational Lung Cancer Research
|
August 25, 2021
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR)
Hibiki Udagawa, Eri Sugiyama, Toshiyuki Harada, et al.
Artificial Organs
|
October 25, 2021
Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patients
Chitaru Kurihara, Adwaiy Manerikar, Catherine Aiyuan Gao, et al.
Translational Lung Cancer Research
|
August 12, 2022
Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)
Satoshi Shoji, Satoru Miura, Satoshi Watanabe, et al.
Cancer Immunology, Immunotherapy : CII
|
October 17, 2021
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer
Miho Takahashi, Satoshi Watanabe, Ryo Suzuki, et al.
Scientific Reports
|
November 21, 2019
Effect of food on the pharmacokinetics and therapeutic efficacy of 4-phenylbutyrate in progressive familial intrahepatic cholestasis
Satoshi Nakano, Shuhei Osaka, Yusuke Sabu, et al.
Japanese Journal of Clinical Oncology
|
January 25, 2024
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study
Hisao Imai, Takashi Kijima, Koichi Azuma, et al.
Translational Lung Cancer Research
|
August 25, 2021
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy
Xuanye Zhang, Dan Tian, Yue Chen, et al.
Communications Biology
|
September 25, 2025
Elucidation of the structure and molecular mechanisms of the aspartate antiporter
Kei Nanatani, Lan Guan, Ryo Kanno, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 6, 2025
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis
Toshiya Fujisaki, Eisaku Miyauchi, Gen Kida, et al.
Iscience
|
March 5, 2024
Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines
Nobuhiko Ogasawara, Yoshihito Kano, Yosuke Yoneyama, et al.
Page
of 82
Search research articles
Search
Showing results (741-750 of 817) with videos related to
Sort By:
Page
of 82
Translational Lung Cancer Research
|
August 25, 2021
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR)
Hibiki Udagawa, Eri Sugiyama, Toshiyuki Harada, et al.
Artificial Organs
|
October 25, 2021
Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patients
Chitaru Kurihara, Adwaiy Manerikar, Catherine Aiyuan Gao, et al.
Translational Lung Cancer Research
|
August 12, 2022
Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)
Satoshi Shoji, Satoru Miura, Satoshi Watanabe, et al.
Cancer Immunology, Immunotherapy : CII
|
October 17, 2021
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer
Miho Takahashi, Satoshi Watanabe, Ryo Suzuki, et al.
Scientific Reports
|
November 21, 2019
Effect of food on the pharmacokinetics and therapeutic efficacy of 4-phenylbutyrate in progressive familial intrahepatic cholestasis
Satoshi Nakano, Shuhei Osaka, Yusuke Sabu, et al.
Japanese Journal of Clinical Oncology
|
January 25, 2024
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study
Hisao Imai, Takashi Kijima, Koichi Azuma, et al.
Translational Lung Cancer Research
|
August 25, 2021
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy
Xuanye Zhang, Dan Tian, Yue Chen, et al.
Communications Biology
|
September 25, 2025
Elucidation of the structure and molecular mechanisms of the aspartate antiporter
Kei Nanatani, Lan Guan, Ryo Kanno, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 6, 2025
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis
Toshiya Fujisaki, Eisaku Miyauchi, Gen Kida, et al.
Iscience
|
March 5, 2024
Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines
Nobuhiko Ogasawara, Yoshihito Kano, Yosuke Yoneyama, et al.
Page
of 82